1. Home
  2. DOGZ vs IKT Comparison

DOGZ vs IKT Comparison

Compare DOGZ & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOGZ
  • IKT
  • Stock Information
  • Founded
  • DOGZ 2003
  • IKT 2008
  • Country
  • DOGZ China
  • IKT United States
  • Employees
  • DOGZ N/A
  • IKT N/A
  • Industry
  • DOGZ Miscellaneous manufacturing industries
  • IKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOGZ Consumer Discretionary
  • IKT Health Care
  • Exchange
  • DOGZ Nasdaq
  • IKT Nasdaq
  • Market Cap
  • DOGZ 165.1M
  • IKT 140.5M
  • IPO Year
  • DOGZ 2017
  • IKT 2020
  • Fundamental
  • Price
  • DOGZ $13.05
  • IKT $1.56
  • Analyst Decision
  • DOGZ
  • IKT Buy
  • Analyst Count
  • DOGZ 0
  • IKT 2
  • Target Price
  • DOGZ N/A
  • IKT $8.00
  • AVG Volume (30 Days)
  • DOGZ 784.5K
  • IKT 93.8K
  • Earning Date
  • DOGZ 10-20-2025
  • IKT 11-13-2025
  • Dividend Yield
  • DOGZ N/A
  • IKT N/A
  • EPS Growth
  • DOGZ N/A
  • IKT N/A
  • EPS
  • DOGZ N/A
  • IKT N/A
  • Revenue
  • DOGZ $20,258,926.00
  • IKT N/A
  • Revenue This Year
  • DOGZ N/A
  • IKT N/A
  • Revenue Next Year
  • DOGZ N/A
  • IKT N/A
  • P/E Ratio
  • DOGZ N/A
  • IKT N/A
  • Revenue Growth
  • DOGZ 46.16
  • IKT N/A
  • 52 Week Low
  • DOGZ $6.81
  • IKT $1.12
  • 52 Week High
  • DOGZ $58.50
  • IKT $4.20
  • Technical
  • Relative Strength Index (RSI)
  • DOGZ 56.44
  • IKT 41.99
  • Support Level
  • DOGZ $9.34
  • IKT $1.50
  • Resistance Level
  • DOGZ $13.74
  • IKT $1.73
  • Average True Range (ATR)
  • DOGZ 1.68
  • IKT 0.10
  • MACD
  • DOGZ 0.15
  • IKT -0.02
  • Stochastic Oscillator
  • DOGZ 65.55
  • IKT 15.08

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: